219 filings
Page 4 of 11
8-K
12ccp31ypagv rvgkeeh
3 Jan 23
Deciphera Pharmaceuticals Announces Planned 2023 Corporate Milestones to Support Continued Evolution to Multi-Product Company
4:13pm
8-K
0coeyytc7k5t512y0t
3 Nov 22
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2022 Financial Results
7:07am
8-K
s7547
12 Sep 22
Regulation FD Disclosure
7:30am
EFFECT
o7xdoeab
11 Aug 22
Notice of effectiveness
12:15am
CORRESP
40nqc7
8 Aug 22
Correspondence with SEC
12:00am
UPLOAD
1zrqq p7jdnc3ec4c
5 Aug 22
Letter from SEC
12:00am
8-K
u0262jtl
4 Aug 22
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results
7:08am
8-K
ht1yhf7vdc
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
5wg aqk80
4 May 22
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results
7:10am
8-K
xlml6n3sl dmpt63vh
27 Apr 22
Entry into a Material Definitive Agreement
9:03pm
424B5
gvgvgvqwdzjo5qf37oxt
27 Apr 22
Prospectus supplement for primary offering
7:35pm
424B5
g9z dsu79bdz
26 Apr 22
Prospectus supplement for primary offering
4:25pm
8-K
sbb 0bduy97etnxfefa
26 Apr 22
Results of Operations and Financial Condition
4:01pm
DEFA14A
efwc3w72o dg1u
26 Apr 22
Additional proxy soliciting materials
7:39am
EFFECT
940c9gmxm43q
11 Mar 22
Notice of effectiveness
12:15am